Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Verzenio (abemaciclib)
Pharma
Lilly shifts oral SERD hopes to its largest oncology trial ever
Lilly will not seek a broad FDA approval for a combination of its oral SERD med Inluriyo and Verzenio despite seemingly promising phase 3 results.
Angus Liu
Dec 12, 2025 11:45am
Lilly blows out tirzepatide sales expectations, raises guidance
Oct 30, 2025 10:39am
ESMO: Eli Lilly looks to drive Verzenio adoption with survival win
Oct 17, 2025 8:00am
Lilly answers Novartis breast cancer rivalry with survival win
Aug 27, 2025 10:59am
Lilly logs huge Q4 revenue jump despite recent incretin letdown
Feb 6, 2025 12:56pm
Kisqali off to a 'very rapid' launch in early breast cancer: CEO
Jan 31, 2025 11:28am
